Teva to drop depression treatment after trial fails

(Reuters) - Generic drugmaker Teva Pharmaceutical Industries Ltd said it will stop development of a depression treatment after a late-stage trial failed to show the drug was more effective than placebo. The study was the third late-stage study that tested Nuvigil, or armodafinil, as an adjunct therapy in adults with major depression associated with bipolar I disorder. While the first late-stage trial had positive results, the second trial failed. Teva said it will not proceed with regulatory filings for the drug for treating bipolar-related depression. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/teva-drop-depression-treatment-trial-fails-164435876--finance.html